A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...

Culture critic Jeevan Sangha unpacks the trajectory and future of Lilly Singh, including her new YouTube show Shame Less.

For tech companies, the healthcare vertical is now the fastest growing business. The US, which spends about $5 trillion on ...

Shares of weight loss and diabetes medication maker Novo Nordisk (NYSE: NVO) have slumped precipitously over the past 52 ...

The National Women's Hall of Fame will sponsor a special screening of the film "Lilly," a new film based on the life of 2011 Hall of Fame ...

Eli Lilly should easily beat the market again in 2025, as it did in 2024. Summit Therapeutics awaits a potentially huge ...

Brisbane-based AdvanCell raised $178 million in one of the biggest funding rounds of 2025 so far. It's good news for an ...

We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where Eli ...

Adding the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) to standard therapy for lupus nephritis is more efficacious ...

Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...